| Chief Scientific Officer & CEO, BioMaraker Solutions. An expert in diagnostic test development and interests in Molecular Pathology and Molecular Genetics he has had the opportunity to design, implement and operate several diagnostic centres in Europe and currently holds the position of Chief Scientific Officer & CEO at BioMarker Solutions. After majoring in chemistry, biochemistry, immunology, and biology in Australia (BSc + MSc with honors) he obtained his Ph.D. in Biochemistry and Medicine in London at Imperial College / University College London. Dr. Murray has 25+ years’ experience in molecular medicine (clinical and molecular genetics, pathology,biochemistry), more than 50 internationally peer-reviewed publications and over 200 presentations (national/ international); he is also a member of several scientific societies, an editorial board member of several international journals, a regular peer reviewer and a recognized KOL in several fields. His special interests include oncology/hematology biomarkers and companion diagnostic(s) development. He is a Director of several companies and maintains research and development ties in academia and industry. Dr. Murray is also a participant in several independent European committees on EQA, bio-safety & diagnostics. He participates in guidelines committees for oncology and biomarkers and is a SAG member of the EMQN. |